Parallax Volatility Advisers’s Alder Biopharmaceuticals ALDR Stock Holding History

Parallax Volatility Advisers’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-87,500	Closed	-$1.38M	–	3994
2018 Q2	$1.38M	Sell	87,500 -25,000	-22%	-$380K	﹤0.01%	1015
2018 Q1	$1.43M	Buy	+112,500	New	+$1.63M	﹤0.01%	864
2015 Q4	–	Sell	-30,000	Closed	-$983K	–	4287
2015 Q3	$983K	Buy	+30,000	New	+$1.28M	﹤0.01%	1298

Other funds holding ALDR

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Parallax Volatility Advisers's ALDR Position: Q1 2019 in Review

Parallax Volatility Advisers sold out of Alder Biopharmaceuticals (ALDR) in Q1 2019, closing a stake of 516 shares — an estimated $5K sold.

Parallax Volatility Advisers first reported a position in ALDR in Q3 2015 and held it in 7 quarters. The position peaked at $653K in Q1 2018. 123 funds tracked by Wall St. Rank hold ALDR as of Q1 2019.

Parallax Volatility Advisers reported no remaining Alder Biopharmaceuticals position as of Q1 2019 after selling out during the quarter.
Parallax Volatility Advisers sold 516 Alder Biopharmaceuticals shares in Q1 2019, an estimated $5K.
Parallax Volatility Advisers first reported a position in Alder Biopharmaceuticals in Q3 2015 and held it in 7 quarters.
Parallax Volatility Advisers's Alder Biopharmaceuticals position peaked at $653K in Q1 2018.
123 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q1 2019.

Based on Parallax Volatility Advisers's 13F filing for Q1 2019, filed 15 May 2019.